Doctor profile · Federal record
Dr. Scott Walter, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Manchester, CT
- NPI 1205127818
- Accepts Medicare
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
191 Main St Ste 3
Manchester, CT 060423574
(860) 646-7704
fax (860) 647-7340
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- June 29, 2021
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State license (1)
- Connecticut #56701
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205127818. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
35,989
Distinct HCPCS
10
Medicare allowed
$2,298,171
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 25,981 | 94 | $37 | |
J3396 |
Injection, verteporfin, 0.1 mg | 1,950 | 12 | $11 | |
92134 |
Imaging of retina | 1,394 | 544 | $42 | |
67028 |
Injection of drug into eye | 885 | 206 | $128 | |
J3299 |
Injection, triamcinolone acetonide (xipere), 1 mg | 720 | 11 | $47 | |
92014 |
Established patient complete exam of visual system | 707 | 420 | $134 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 585 | 19 | $151 | |
J0178 |
Injection, aflibercept, 1 mg | 522 | 63 | $871 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 409 | 22 | $225 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 378 | 254 | $16 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 899. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$110,286
Transactions
95
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 29 | $50,140.91 | |
| Apellis Pharmaceuticals, Inc. | 17 | $29,490.23 | |
| Genentech USA, Inc. | 11 | $13,290.85 | |
| Bausch & Lomb Americas Inc. | 11 | $6,781.28 | |
| Regeneron Pharmaceuticals, Inc. | 3 | $3,399.29 | |
| Astellas Pharma US Inc | 6 | $2,629.97 | |
| F. Hoffmann-La Roche AG | 2 | $2,325.90 | |
| Lupin Inc. | 1 | $1,494.00 | |
| Genentech, Inc. | 1 | $144.72 | |
| Mallinckrodt Hospital Products Inc. | 2 | $142.17 | |
| Alimera Sciences, Inc. | 5 | $108.52 | |
| Alcon Vision LLC | 1 | $97.96 | |
| ABBVIE INC. | 3 | $77.68 | |
| Immunocore Limited | 2 | $57.10 | |
| Sandoz Inc. | 1 | $39.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,155
Patients
541
Total drug cost
$99,066
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 258 | 158 | $17,981 |
| Latanoprost | Generic | 167 | 45 | $3,294 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 165 | 67 | $3,493 |
| Prolensa (Bromfenac Sodium) | Brand | 126 | 40 | $45,850 |
| Polymyxin B Sul-Trimethoprim (Polymyxin B Sulf/Trimethoprim) | Brand | 106 | 95 | $981 |
| Cyclopentolate Hcl | Generic | 82 | 64 | $1,359 |
| Atropine Sulfate | Generic | 44 | 27 | $2,479 |
| Brimonidine Tartrate | Generic | 43 | 14 | $2,016 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 34 | 20 | $400 |
| Loteprednol Etabonate | Generic | 26 | 0 | $5,903 |
Frequently asked questions
What is Dr. Scott Walter's medical specialty?
Dr. Scott Walter practices Retina Specialist (Ophthalmology) Physician in Manchester, CT.
Where does Dr. Scott Walter practice?
Dr. Scott Walter practices at 191 Main St Ste 3, Manchester, CT 060423574. Office phone: 8606467704.
What is Dr. Scott Walter's NPI?
Dr. Scott Walter's National Provider Identifier (NPI) is 1205127818, issued by NPPES.
Does Dr. Scott Walter accept Medicare assignment?
Yes. Dr. Scott Walter accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Scott Walter commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, verteporfin, 0.1 mg (HCPCS J3396); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.